These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7247374)

  • 1. Trimethoprim-rifampin, a new combination agent: efficacy in localized urinary infection and influence on microflora.
    Bourgault AM; Forward KR; Ronald AR; Harding GK; Thomson M; Grey G
    Antimicrob Agents Chemother; 1981 Apr; 19(4):513-8. PubMed ID: 7247374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.
    Stein GE; Gurwith D; Gurwith M
    Antimicrob Agents Chemother; 1988 Jun; 32(6):802-6. PubMed ID: 3046481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
    Haase DA; Harding GK; Thomson MJ; Kennedy JK; Urias BA; Ronald AR
    Antimicrob Agents Chemother; 1984 Oct; 26(4):481-4. PubMed ID: 6240223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifaprim in urinary tract infection: a comparison with co-trimoxazole.
    Kosmidis J; Giamarellou H; Papadakis M; Eliades E; Daikos GK
    J Antimicrob Chemother; 1983 Mar; 11(3):239-44. PubMed ID: 6601648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim once daily vs. nitrofurantoin in treatment of acute urinary tract infections in young women, with special reference to periurethral, vaginal, and fecal flora.
    Iravani A; Richard GA; Baer H
    Rev Infect Dis; 1982; 4(2):378-87. PubMed ID: 7202249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rifampin for the treatment of urinary tract infections.
    Brumfitt W; Dixson S; Hamilton-Miller JM
    Rev Infect Dis; 1983; 5 Suppl 3():S573-82. PubMed ID: 6635448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim alone for treatment of urinary tract infection.
    Neu HC
    Rev Infect Dis; 1982; 4(2):366-71. PubMed ID: 7051236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women.
    Harding GK; Ronald AR; Nicolle LE; Thomson MJ; Gray GJ
    Rev Infect Dis; 1982; 4(2):438-43. PubMed ID: 6981161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim alone in the treatment of urinary tract infections: eight years of experience in Finland.
    Kasanen A; Sundquist H
    Rev Infect Dis; 1982; 4(2):358-65. PubMed ID: 7051235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora.
    Iravani A; Richard GA; Baer H
    Antimicrob Agents Chemother; 1981 May; 19(5):842-50. PubMed ID: 7027925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General survey of trimethoprim combinations in the treatment of urinary tract infections.
    Brumfitt W; Hamilton-Miller JM
    Infection; 1979; 7 Suppl 4():S388-93. PubMed ID: 511353
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.
    Iravani A; Richard GA; Baer H; Fennell R
    Antimicrob Agents Chemother; 1981 Apr; 19(4):598-604. PubMed ID: 6972732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.
    Ronald AR; Harding CK; Mathias R; Wong CK; Muir P
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):13-6. PubMed ID: 1137829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
    Harding GK; Ronald AR; Boutros P; Lank B
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of rifampin and trimethoprim in vitro.
    Alvarez S; DeMaria A; Kulkarni R; Klein JO; McCabe WR
    Rev Infect Dis; 1982; 4(2):390-401. PubMed ID: 7111962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind multicenter trial of a rifampicin-trimethoprim combination and rifampicin alone in urinary tract infections.
    Palminteri R; Sassella D
    Chemotherapy; 1979; 25(3):181-8. PubMed ID: 378574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of the rifampin-trimethoprim combination (Rifamprim) in the treatment of chronic upper urinary tract infection].
    Arosio E; Romeo B; Pancera P; Fraizzoli G; Mengoli C; Lechi A
    G Ital Chemioter; 1979; 26(1-2):343-8. PubMed ID: 400147
    [No Abstract]   [Full Text] [Related]  

  • 18. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection.
    Smellie JM; Grüneberg RN; Normand IC; Bantock HM
    Rev Infect Dis; 1982; 4(2):461-6. PubMed ID: 6981164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.
    Pancoast SJ; Hyams DM; Neu HC
    Antimicrob Agents Chemother; 1980 Feb; 17(2):263-8. PubMed ID: 7387147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.